Statement by Mr. Nicolas Sarkozy, President of the Republic, on organ transplants and biomedical research in France, in Villejuif on September 18, 2009.

France Nicolas Sarkozy · President of France

18 September 2009 · Statement on organ transplants and biomedical research in France · Paul-Brousse Hospital, Villejuif, France

Context
Sarkozy addressed transplant recipients, medical teams, and staff at Paul-Brousse Hospital in Villejuif on September 18, 2009, marking the center's 2,500th liver transplant.
Main themes
Organ donation and transplantation, biomedical research, donor solidarity, hospital staff tribute, liver transplantation milestones, transplant waiting list crisis, Paul-Brousse Hospital legacy, state duty in public health, bone marrow donation, medical pioneers recognition
Duration
~22 min
70th percentile
Words
2,661
70th percentile
Sentences
166
84th percentile
Readability
56
78th percentile
Grade
9.4
15th percentile
Syntax
2.72
15th percentile
Vocabulary
2.19
47th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 62%62%
  • Ceremonial 19%19%
  • Institutional 11%11%
  • Economic 5%5%
  • Technological 3%3%
  • Geopolitical 0%0%
  • Environmental 0%0%
  • Not in focus 0%

166 sentences in 48 paragraphs

Ladies and gentlemen,

Dear Roselyne,

Dear Valérie,

Ladies and gentlemen, members of Parliament,

Madam Mayor,

Ladies and gentlemen, elected officials,

Mr. President,

Mr. Director General,

Ladies and gentlemen, professors,

And if you will allow me, dear friends,

Last February, the hepatobiliary center of Paul-Brousse Hospital performed its 2,500th liver transplant. This is a major milestone in the long and beautiful history of liver transplantation in France, a history that began in the late 1960s.

Since then, the teams at the hepatobiliary center have given life back to 2,500 people who were on the brink of death due to severe liver disease.

Liver transplantation, which was once a feat, a tour de force just a few decades ago, is now a proven technique, a safe technique that combines several medical and surgical disciplines.

It allows hundreds of people like you to lead normal lives. Many children transplanted here have reached adulthood, work, and live normally. Fifty women transplanted here have been able to have children of their own. With transplantation, life resumes its rights. Life returns to its normal course. And it is the role of the President of the Republic to be here to meet with transplant recipients, to call on our fellow citizens to donate, and to congratulate the teams. But to be honest, I find it particularly incomprehensible that there could be any controversy over the presence of the President of the Republic among the transplant recipients, among the medical teams, because what would be scandalous is that I am not here, not that I am here. There are subjects that do not belong to petty politics, regardless of one's convictions. The duty to support those who donate their organs and the duty to support the medical teams is a duty of the State. You have done very well to organize this anniversary. It goes far beyond the differences among us. I am also very happy that Mr. LE GUEN is by our side, representing the management of AP-HP. This is the duty of the State, and I truly feel sorry for those who create controversies. They must be so unhappy in their lives that they do not understand the stakes. And you, who have come so close to losing your lives, understand the stakes because of your difference.

I know that to be perfectly mastered, transplantation remains a miracle, like a resurrection.

I want to pay tribute in turn to the pioneers, surgeons, doctors, radiologists, biologists, and researchers, nurses who created this center.

You warmly welcomed Professor Henri BISMUTH, but he deserves all the love he inspires around him, that man. Dear Henri BISMUTH, when you look back on your life, you have a great privilege; you do not ask yourself if you have been useful, you know you have. That is why your life is a great life and why you have been surrounded by so many signs of affection.

I want to pay tribute to Professors René ADAM, Denis CASTAING, and Didier SAMUEL, who continue the work - we can say - of their master. It does not diminish one to have a master; on the contrary, it is a chance. I want to pay tribute to all the staff who are here. I would like to tell them that regardless of their responsibilities, and my friend, Roselyne BACHELOT knows this, I enjoy meeting the hospital staff because it is a place where there is passion. All the professions in the hospital - doctors, healthcare staff, non-medical staff - are hard jobs. But all those who practice them share a common passion. Many have told me: "We need more money, more resources." I understand that, and I want to say that the demands of the hospital community are perfectly legitimate because they are commensurate with their commitment.

I am late because we took a lot of time during the visit. I apologize to you for that. People are so happy to work where they work, so passionate, and you have to see the service that is the best, the team that is the best. There is an enthusiasm that is a pleasure to see, and I would love for the spirit of the hospital community in France to shine in so many other communities across our country that would need this enthusiasm, this commitment, and this will to overcome all difficulties. Really, I want to express the pleasure I have in being among you.

At the beginning of everything, there is the question of donors. We must pay tribute to the donors. Organ donors, blood donors, platelet donors, bone marrow donors, as we are in this fourth national week of bone marrow donation.

The gift of oneself. Donation is an act of solidarity. Everyone talks about solidarity in our country, but there are solidarities that are even more fundamental than others, and donors must be highlighted as examples of generosity in our society.

In 2008, 4,600 transplants, across all organs, were performed in France. Yet, 14,000 patients are waiting for a transplant. This single figure warranted my presence. And in 2008, 222 people died because they were not transplanted in time. We cannot let this reality, which is a tragedy, go unnoticed. Even if there had been only one, that alone deserves us to mobilize to tell the French: "You are healthy; you do not realize what it means to be sick and what you can do by donating, whatever the donation you make."

Every year, the list of patients waiting grows longer. Every year, the gap widens. We cannot bear this situation.

I therefore call on everyone's sense of responsibility. I invite everyone to talk about organ donation with family, with loved ones, so that their position regarding donation is known and shared.

In our law, consent to donation is presumed to be granted. Everyone implicitly consents to donate their organs unless they have registered on a refusal list with the Agency for Biomedicine. However, this subject must have been discussed beforehand with their loved ones. Otherwise, ladies and gentlemen, when a death occurs that overwhelms an entire family with grief, the discussion around donation becomes delicate, even impossible. If it has not been talked about beforehand, it is not at the moment when the person left behind is overwhelmed with grief that these questions can be raised.

I wish that throughout the year, debates and events related to organ donation, blood donation, platelet donation, and bone marrow donation intensify. The gift of oneself should not be a subject reserved for experts or the sick. Donation is everyone's business. It is a matter of national interest.

2009, the year of the great national cause, marks the beginning of a new surge in organ donation in our country.

I call for the dissemination of new modalities of donation. Living donor transplantation must progress. It concerns less than 5% of transplants here at Paul-Brousse. It is 40% in Norway. There is no reason for this gap to exist. Living donor transplantation carries certain risks, like any major surgical act. But, performed by high-level teams, it is a controlled act.

I also think of paired donation, which is practiced in all European countries. We must use it more often. The revision, dear Roselyne, of the bioethics law can be an opportunity to create the conditions for this type of transplantation to develop.

The noble mission carried out every day by your teams is the very expression of the quality of French medicine and research. We are here in a place of excellence, in a place of care, dear Jean-Marie LE GUEN, which would not be what it is without research. We are in a research place whose reason for being is its proximity to the care provided to patients. We are also in a place of teaching, hence the presence of Valérie PECRESSE alongside Roselyne BACHELOT, because the two go hand in hand: research and health.

300 professionals are gathered here around the patient, 20% of foreign patients, 500 square meters dedicated to research within a mixed INSERM - University Paris XI unit. We must break down the walls. Research is the great affair of the university, and university hospitals must be centers dedicated to care but also to research and teaching. Here, it is a true "Institute of the Liver" through the alliance of all competencies; the most modern techniques are implemented. The experience you have gained is irreplaceable. You have here transplanted for the first time in the world a reduced adult liver to a child. You have developed the technique that allows, from a single liver, to transplant two recipients. You use the artificial liver and the bio-artificial liver.

This is an exceptional success. You are a model for all biomedical research in France.

It is around institutes of this type that our best research teams must build common projects. Our country needs a few centers of excellence. We should not be afraid to distinguish centers that are more excellent than others; equality is not leveling down. No one should fear that a center like yours is designated particularly because of its excellence. This will pull all the others up. Research cannot accommodate leveling down. We need about ten centers like yours, covering different areas of life sciences and health.

A few months ago, the commission chaired by Jacques MARESCAUX presented us, along with Roselyne Bachelot, its proposals. Several of them concerned governance: they have been integrated into the "Hospital" law. But there are others that have not yet been implemented. I am thinking in particular of the labeling of hospital-university institutes that are very close to the center we know here.

IHUs, hospital-university institutes, will be platforms for care, research, and teaching that we want to be of world-class level, organized around a coherent scientific project. In connection with a university hospital, they must be able to benefit from a management delegation and establish advanced relationships with their university. They will have the opportunity to recruit the best professionals, both French and foreign, thanks to contracts that will be attractive. If we want the best, we must pay them. It costs less to have the best than the opposite. It may be time for our country to draw inspiration from everything that works elsewhere. We have extensively experimented with everything that does not work elsewhere. The quality of the services of the professionals we will bring to these IHUs will be rewarded at its true value. These institutes that we envision with Roselyne BACHELOT must also attract private funds. The public hospital will not lose its soul if there are private funds that allow us to have the best professionals, the best techniques, and the best investments. Let us move beyond this sectarianism. We need the meeting of all competencies. Private funding will allow us to access another dimension and, I will tell you, to create the gap with our foreign competitors.

I wish for a call for proposals to label the first hospital-university institutes to be organized in 2010. I announce to you that an international jury will propose to the government to grant the label "hospital-university institute" to a maximum of five centers of excellence. A second call for proposals could take place afterward. If we make everyone believe that they have a global dimension, no one will have a global dimension. All French people must have access to quality health care, but we must mobilize resources to have world-class centers of excellence.

I ask Valérie PECRESSE, I trust her completely, and she knows it, to prepare, in conjunction with Roselyne BACHELOT, the launch of the call for proposals. Perhaps Valérie, we could ask that Professor MARESCAUX and the commission he chaired receive as a new mission to clarify the concept of hospital-university institute at the scientific level, and there are many discussions to be had regarding management and funding, of course. They could also define the concrete modalities of the call for proposals.

I am aware that, of course, France's needs in the field of health will be even greater tomorrow: aging population, emergence of new diseases, the appearance of pandemics, such as the H1N1 flu; I want to once again pay tribute to Roselyne Bachelot for the quality of her work in managing this crisis.

In the face of these challenges, our country has remarkable assets. Our medical school is old and renowned. Some of our university hospitals offer care that the whole world envies us. Our country has been honored with several Nobel Prizes, the most recent being that of Françoise BARRÉ-SINOUSSI in 2008.

What I wish is for the landscape of medical research to evolve profoundly. Public research organizations have come together in a Life Sciences and Health Alliance, whose thematic institutes play a role in stimulating and programming research. And our universities, finally having gained autonomy, are meant to be the operators of biomedical research.

Our country has several dozen biotechnology companies. But biotechnology, I assert, in France, remains a market that is too narrow. The prospects for development will be promising, but there is not enough connection with industry.

I am convinced that we can make life sciences and health the engine of our economy of tomorrow.

I have a proposal: that the national loan, which the Government will have to arbitrate at the end of the year, could finance certain investments in life sciences. I am thinking in particular of the IHU that I just mentioned. I would like to submit this idea to the commission chaired by Michel ROCARD and Alain JUPPÉ, which is currently working on the investment priorities of our country in view of the national loan. If the commission were to adopt this proposal, granting the label "university hospital institute" to a center of biomedical excellence would make all or part of its investments eligible for financing from the national loan.

What is more precious than our health? And who can tell me that the market will be sufficient to finance research that is extremely costly? We issue a call for proposals, we designate a small number of global centers of excellence to avoid dispersing efforts—which is a French disease—and we mobilize part of the funds that we will make available to the country to prepare for the future in service of financing these university hospital institutes. I believe this is a choice—and I say this to all the parliamentarians who are here—that can transcend left-right divides. Investment in biomedical research, in knowledge, has nothing to do with the small daily political debates, even if those can be important.

Ladies and Gentlemen,

That is what I wanted to tell you. Health is a key sector of the knowledge economy. Here, you are doing absolutely remarkable work, and I have been honored by your invitation. I have also been happy to see women and men who must have gone through difficult times, because I imagine that when you are told about illness and when you are told about transplantation, it must not be among the most pleasant moments of your life, even if you trust your doctor. There is the moment of the operation. There is the moment of the aftermath of the operation. There is the hope that returns. And then for some, there is the relapse, and one must go through the same inexorable path again. We thought we had gotten through it, having those bad memories behind us, and here we are needing to muster all our courage to start over.

I want to tell you, Ladies and Gentlemen, it is I who admire you and it is I who respect you, because all those I have seen have told me with a big smile: "You know, I have been transplanted once, twice, three times!" Well, I wonder if I would have had the courage to have the same smile in your place. I have been very happy to be with you. I hope you understood that.

Thank you.